DALE H CONAWAY

CIK 1261770 · last filed 2025-11-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

23

Lifetime Open-Market Net

$5.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
GALECTIN THERAPEUTICS INC (PRW) Delisted	Director	22,806	—	—	$5.3K	8	2008-03-17

Recent Filings · Page 2 of 3

23 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-01-18	—	Grant (A)	+110,000	$5.2K
2021-01-19	—	Grant (A)	+227,800	$54.7K
2020-12-14	—	Grant (A)	−22,000	-$132
2015-06-08	—	Buy (P)	+5,000	$600
2009-02-11	—	Grant (A)	—	$0
2008-03-17	GALECTIN THERAPEUTICS INC (PRW) Delisted	Grant (A)	—	$0	EDGAR
2007-11-13	GALECTIN THERAPEUTICS INC (PRW) Delisted	Grant (A)	—	$0	EDGAR
2007-04-02	GALECTIN THERAPEUTICS INC (PRW) Delisted	Buy (P)	+400	$300	EDGAR
2007-03-13	GALECTIN THERAPEUTICS INC (PRW) Delisted	Grant (A)	—	$0	EDGAR
2007-03-13	GALECTIN THERAPEUTICS INC (PRW) Delisted	Buy (P)	+60	$72	EDGAR

Showing 11–20 of 23

Prev Page 2 of 3 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.